Q2GEP2 AF NFT

Alanine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidx6pmop6zinrwgbxdu4pevi6le3lvnmb66apbb2yydwp4aldxci4/metadata.json
IPFS of structure file: 
bafybeibv2gprz2egqr2uun5q22wk3chyploqtjiplhifqvqbjywld43nve/AF-Q2GEP2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x24c1edb3DD9C691e235aB9D784325EA74d43a870
First NFT owner address (bech32): 
genesis1ynq7mv7an353ug66h8tcgvj75ax582rs639se7
Current NFT ID #443243 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
443243
Accession (UniProt):
Q2GEP2
Name::
Alanine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Neorickettsia sennetsu (strain ATCC VR-367 / Miyayama)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q2GEP2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q2GEP2|SYA_NEOSM Alanine--tRNA ligase OS=Neorickettsia sennetsu (strain ATCC VR-367 / Miyayama) OX=222891 GN=alaS PE=3 SV=1 MIDGLRKKFIDFFVKNGHTYLPSASLVPKDDPSLMFVNAGMVPFKEYFVDVRRAPFSSIVTAQKCVRAGGKHNDLENVGFTKRHHTFFEMLGNFSFGCYFKERAIELAWKFVTEELTLSKKKLYITVYHEDDEAFEIWDKLTGFGERKIKRISTSDNFWQMGDIGPCGPCSEIFYDHGEHLSGDIPEDKKDPGERYVEIWNLVFMQYIREQSGELARMECPCIDTGMGLERVAAILEGTDDNYKTKLFEAIVKESQNVTGNKDNQAAHKVIADHLRSASFLIADGVLPGNTGREYVLRRIIRRAVRYSHALGFDTVLLPKLFWVLKEWMGSHYQELTRAENLILDTLTLEEQSFRNTLKSGMKLLEEVSSSMKEGDTLSGDIAFTLYDTHGFPLDITVDILKERKISVDEEGFAERMKMQRLLAQASRMKDMAQTSSYEVKAVFLEHGKTPFIGYENFTGLALILAITEKEGSNKLTIILDQTIFYPESGGQESDQGIIEGENTLLKVEKVYKSTEGVILHECTIIRGQVTSRGEKVNLKIDINRRNSLARNHSATHILHHVLRKRLGAHVSQRGSLVAPSRLRFDFSHSQSITEEELSKIEDCINLMIWDDHPVMTEIKKTDEAIRDGAIGLFGEKYDDTVRVVSIGEAVELCGGTHVKKSSAIGLVKILSASSVAHGVRRIEAVTHLTALQYIREAEQAQLYQLTEHQAKLKAMQKSHQKEITRVYQSIVTNAEARTERYGSVEIITKNVQGISKEILLSLASEIRPKTGVLIVHTELSEALYSLIILDKEIFKNISFIDSMKETIDKSHGKVTPSVPYVIQATFSKKEDLDRCLKNLSELVVSTF